Co neurolog powinien wiedzieć, konsultując pacjenta przed zabiegiem chirurgicznym, co powinien powiedzieć pacjentowi i co jest ważne dla anestezjologa Artykuł przeglądowy
##plugins.themes.bootstrap3.article.sidebar##
Opublikowane:
gru 31, 2018
Słowa kluczowe:
stwardnienie rozsiane, znieczulenie, zabieg chirurgiczny
##plugins.themes.bootstrap3.article.main##
Abstrakt
Znieczulenie pacjenta z rozpoznaniem stwardnienia rozsianego ze względu na liczbę możliwych powikłań w okresie okołooperacyjnym stanowi wyzwanie dla anestezjologa. Jakkolwiek techniki anestezjologiczne stały się bezpieczniejsze na przestrzeni lat, to współpraca interprofesjonalna ma zasadniczy wpływ na bezpieczeństwo wykonywanych procedur. Bardzo istotną rolę w tym zakresie odgrywa konsultacja neurologiczna opisująca stan zdrowia chorego oraz ewentualne zalecenia dotyczące postępowania okołooperacyjnego. Pozwala to na optymalne przygotowanie pacjenta do planowanej procedury.
##plugins.themes.bootstrap3.article.details##
Numer
Dział
Artykuły
Copyright © by Medical Education. All rights reserved.
Bibliografia
1. Dickerman R.D., Schneider S.J., Stevens Q.E. et al.: Prophylaxis to avert exacerbation/relapse of multiple sclerosis in affected patients undergoing surgery. Surgical observations and recommendations. Journal of Neurosurgery Sciences 2004; 48(3): 135-137.
2. Kroencke D.C., Denney D.R.: Stress and coping in multiple sclerosis: exacerbation, remission and chronic subgroups. Multiple Sclerosis 1999; 5: 89-93.
3. Egbert L.D., Battit G.E., Welch C.E. et al.: Reduction of post-operative pain by encouragement and instruction of patients. New England Journal of Medicine 1964; 270(16): 825-827.
4. Ramsay M.A.E.: A survey of pre-operative fear. Anaesthesia 1972; 27(4): 396-402.
5. Cobley M., Dunne J.A., Sanders L.D.: Stressful pre-operative preparation procedures: the routine removal of dentures during pre-operative preparation contributes to pre-operative distress. Anaesthesia 1991; 46(12): 1019-1022.
6. McCleane G.J., Cooper R.: The nature of pre-operative anxiety. Anaesthesia 1990; 45(2): 153-155.
7. Mishel M.H.: The measurement of uncertainty in illness. Nursing Research 1981; 30: 258-263.
8. Badner N.H., Nielson W.R., Munk S. et al.: Pre-operative anxiety: detection and contributing factors. Canadian Journal of Anaesthesia 1990; 37(4): 444-447.
9. Altintas A., Demir T., Ikitimur H.D. et al.: Pulmonary function in multiple sclerosis without any respiratory complaints. Clinical Neurology Neurosurgery 2007; 109: 242-246.
10. Smeltzer S.C., Skurnick J.H., Troiano R. et al.: Respiratory function in multiple sclerosis. Utility of clinical assessment of respiratory muscle function. Chest 1992; 101: 479-484.
11. Racke M., Lovett-Racke A., Krandikar N.: The mechanism of action of glatiramer acetate treatment in multiple sclerosis. Neurology 2010; 74: 25-30.
12. Dahdaleh D., Altmann D.M., Malik O. et al.: Breathlessness, night sweats, and weight loss on natalizumab. Lancet 2012; 380: 726-727.
13. Cohen J.A., Barkhof F., Comi G. et al.; TRANSFORMS Study Group: Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis. New England Journal of Medicine 2010; 362: 402-415.
14. King A.M., Menke N.B., Katz K.D. et al.: 4-Aminopyridine toxicity: a case report and review of the literature. Journal of Medical Toxicology 2012; 8: 314-321.
15. Kulkarni L.M., Sanikop C.S., Shilpa H.L. et al.: Anaesthetic management in a patient with multiple sclerosis. Indian Journal of Anaesthesia 2011; 55(1): 64-67.
16. Lirk P., Birmingham B., Hogan Q.: Regional anesthesia in patients with preexisting neuropathy. International Anesthesiology Clinics 2011; 49: 144-165.
17. Vercauteren M., Heytens L.: Anaesthetic considerations for patients with a pre-existing neurological deficit: are neuraxial techniques safe? Acta Anaesthesiologica Scandinavica 2007; 51: 831-838.
18. Martucci G., Di Lorenzo A., Polito F. et al.: A 12-month follow-up for neurological complication after subarachnoid anesthesia in a parturient affected by multiple sclerosis. European Review Medical Pharmacological Sciences 2011; 15: 458-460.
19. Hines R., Marschall K.: Handbook for Stoelting’s Anaesthesia and Co-Existing Disease. 3rd ed. Saunders Elsevier 2009.
20. Bader A.M., Hunt C.O., Datta S. et al.: Anesthesia for the obstetric patient with multiple sclerosis. Journal of Clinical Anesthesia 1988; 1: 21-24.
21. Compston A., Coles A.: Multiple sclerosis. Lancet 2008; 372: 1502-1517.
22. Hebl J.R., Horlocker T.T., Schroeder D.R.: Neuraxial anesthesia and analgesia in patients with preexisting central nervous system disorders. Anesthesia and Analgesia 2006; 103: 223-228.
2. Kroencke D.C., Denney D.R.: Stress and coping in multiple sclerosis: exacerbation, remission and chronic subgroups. Multiple Sclerosis 1999; 5: 89-93.
3. Egbert L.D., Battit G.E., Welch C.E. et al.: Reduction of post-operative pain by encouragement and instruction of patients. New England Journal of Medicine 1964; 270(16): 825-827.
4. Ramsay M.A.E.: A survey of pre-operative fear. Anaesthesia 1972; 27(4): 396-402.
5. Cobley M., Dunne J.A., Sanders L.D.: Stressful pre-operative preparation procedures: the routine removal of dentures during pre-operative preparation contributes to pre-operative distress. Anaesthesia 1991; 46(12): 1019-1022.
6. McCleane G.J., Cooper R.: The nature of pre-operative anxiety. Anaesthesia 1990; 45(2): 153-155.
7. Mishel M.H.: The measurement of uncertainty in illness. Nursing Research 1981; 30: 258-263.
8. Badner N.H., Nielson W.R., Munk S. et al.: Pre-operative anxiety: detection and contributing factors. Canadian Journal of Anaesthesia 1990; 37(4): 444-447.
9. Altintas A., Demir T., Ikitimur H.D. et al.: Pulmonary function in multiple sclerosis without any respiratory complaints. Clinical Neurology Neurosurgery 2007; 109: 242-246.
10. Smeltzer S.C., Skurnick J.H., Troiano R. et al.: Respiratory function in multiple sclerosis. Utility of clinical assessment of respiratory muscle function. Chest 1992; 101: 479-484.
11. Racke M., Lovett-Racke A., Krandikar N.: The mechanism of action of glatiramer acetate treatment in multiple sclerosis. Neurology 2010; 74: 25-30.
12. Dahdaleh D., Altmann D.M., Malik O. et al.: Breathlessness, night sweats, and weight loss on natalizumab. Lancet 2012; 380: 726-727.
13. Cohen J.A., Barkhof F., Comi G. et al.; TRANSFORMS Study Group: Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis. New England Journal of Medicine 2010; 362: 402-415.
14. King A.M., Menke N.B., Katz K.D. et al.: 4-Aminopyridine toxicity: a case report and review of the literature. Journal of Medical Toxicology 2012; 8: 314-321.
15. Kulkarni L.M., Sanikop C.S., Shilpa H.L. et al.: Anaesthetic management in a patient with multiple sclerosis. Indian Journal of Anaesthesia 2011; 55(1): 64-67.
16. Lirk P., Birmingham B., Hogan Q.: Regional anesthesia in patients with preexisting neuropathy. International Anesthesiology Clinics 2011; 49: 144-165.
17. Vercauteren M., Heytens L.: Anaesthetic considerations for patients with a pre-existing neurological deficit: are neuraxial techniques safe? Acta Anaesthesiologica Scandinavica 2007; 51: 831-838.
18. Martucci G., Di Lorenzo A., Polito F. et al.: A 12-month follow-up for neurological complication after subarachnoid anesthesia in a parturient affected by multiple sclerosis. European Review Medical Pharmacological Sciences 2011; 15: 458-460.
19. Hines R., Marschall K.: Handbook for Stoelting’s Anaesthesia and Co-Existing Disease. 3rd ed. Saunders Elsevier 2009.
20. Bader A.M., Hunt C.O., Datta S. et al.: Anesthesia for the obstetric patient with multiple sclerosis. Journal of Clinical Anesthesia 1988; 1: 21-24.
21. Compston A., Coles A.: Multiple sclerosis. Lancet 2008; 372: 1502-1517.
22. Hebl J.R., Horlocker T.T., Schroeder D.R.: Neuraxial anesthesia and analgesia in patients with preexisting central nervous system disorders. Anesthesia and Analgesia 2006; 103: 223-228.